Brstilo, L.; Reyes Valenzuela, G.; Caraballo, R.; Pérez Montilla, C.; GarcÃa Bournissen, F.; Cáceres Guido, P.; Schaiquevich, P.
Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies. Pharmaceutics 2023, 15, 2120.
https://doi.org/10.3390/pharmaceutics15082120
AMA Style
Brstilo L, Reyes Valenzuela G, Caraballo R, Pérez Montilla C, GarcÃa Bournissen F, Cáceres Guido P, Schaiquevich P.
Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies. Pharmaceutics. 2023; 15(8):2120.
https://doi.org/10.3390/pharmaceutics15082120
Chicago/Turabian Style
Brstilo, Lucas, Gabriela Reyes Valenzuela, Roberto Caraballo, Carlos Pérez Montilla, Facundo GarcÃa Bournissen, Paulo Cáceres Guido, and Paula Schaiquevich.
2023. "Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies" Pharmaceutics 15, no. 8: 2120.
https://doi.org/10.3390/pharmaceutics15082120
APA Style
Brstilo, L., Reyes Valenzuela, G., Caraballo, R., Pérez Montilla, C., GarcÃa Bournissen, F., Cáceres Guido, P., & Schaiquevich, P.
(2023). Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies. Pharmaceutics, 15(8), 2120.
https://doi.org/10.3390/pharmaceutics15082120
